Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Tengion Announces Closing of $15.0 Million of Senior Secured Convertible Notes Due 2015 

 

 

Tengion Announces Closing of $15.0 Million of Senior Secured Convertible Notes Due 2015

October 10, 2012 - (Tengion) - "Tengion, Inc., a leader in regenerative medicine, today announced  the closing of its previously announced private placement of $15.0 million aggregate principal amount of Senior Secured Convertible Notes (the "Notes"), with certain investors, including Celgene Corporation, RA Capital Management LLC, Deerfield Management Company, LP, Bay City Capital and HealthCap.  As part of its investment, Celgene Corporation secured a right of first negotiation on the Company's Neo-Urinary Conduit™ program."  Read Full Article

 

Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: